Please assess the completion status of the following clinical trial:

Trial Title: Aspirin Resistance and Sleep Apnea in Type-2 Diabetic Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Men and women aged \> 18 years old~* With Type 2 diabetes~* Stable Atherothrombosis for more than 3 months~* Using aspirin for more than 10 days or without aspirin (in this last case, they will do only the observational study.)~* Without any modification in their treatments for 10 days~* Ambulatory patient~* Without any cardiovascular event or inflammatory disease for 3 months before inclusion~Exclusion Criteria:~* Pregnant women~* Other active clinically significant illness, including unstable cardiovascular, or neoplasia which could interfere with the study conduct or counterindicate the study treatments or place the patient at risk during the trial or compromise the study participation~* Patients participating in an other study~* Patient without any medical care insurance~* Any treatment that could interfere with aspirin~* Previous treatment by CPAP

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- CPAP (Type: ACTIVE_COMPARATOR): This device consists in a nasal continuous positive airway pressure (CPAP). It will be applied 3 months after the beginning of drug treatment and for 3 months.~Other Name: positive airway pressure
- Sham-CPAP (Type: PLACEBO_COMPARATOR): This device consists in a sham CPAP. It will be applied 3 months after the beginning of drug treatment and for 3 months.

Based on this trial design, predict the completion outcome and termination type (if applicable).